Financial Performance - Total revenue for the nine months ended September 30, 2024, was 1,593,854,adecreasefrom5,542,749 for the same period in 2023[14] - Operating loss for the nine months ended September 30, 2024, was (17,131,765),comparedto(20,891,533) for the same period in 2023, indicating an improvement[14] - Net loss for the nine months ended September 30, 2024, was (16,316,664),comparedto(11,144,012) for the same period in 2023[14] - Basic loss per share for the nine months ended September 30, 2024, was (8.54),comparedto(9.92) for the same period in 2023[14] - Total costs and expenses for the nine months ended September 30, 2024, were 18,468,014,comparedto26,434,282 for the same period in 2023[14] - Total revenue for the three months ended September 30, 2024, was 370,187,adecreaseof76.81,593,854 for the same period in 2023[65] - For the three months ended September 30, 2024, total revenue decreased by 1,223,667or774,206,500 or 76% compared to the same period in 2023, driven by similar factors[183] Cash and Liquidity - Cash and cash equivalents increased to 2,915,757asofSeptember30,2024,from753,398 as of December 31, 2023[13] - Cash and cash equivalents at the end of the period on September 30, 2024, were 2,915,757,downfrom6,771,531 at the end of the same period in 2023[23] - The company reported a net cash used in operating activities of (20,128,427)fortheninemonthsendedSeptember30,2024,comparedto(16,626,631) in the prior year[23] - The company received net proceeds of 22,346,163fromdebtandequityfinancingduringtheninemonthsendedSeptember30,2024[193]−Thecompanymayrequireadditionalliquiditytocontinueoperationsoverthenexttwelvemonths,withacurrentinvestorcommittedtoprovidesupport[192]AssetsandLiabilities−Totalcurrentliabilitiesdecreasedto13,135,564 as of September 30, 2024, from 17,387,236asofDecember31,2023[13]−Totalassetsdecreasedto24,987,925 as of September 30, 2024, from 26,148,475asofDecember31,2023[13]−Totalliabilitiesdecreasedto61,493,781 as of September 30, 2024, from 67,935,325asofDecember31,2023[13]−Totalstockholders′equity(deficit)asofSeptember30,2024,was(36,505,856), a decrease from (2,676,314)asofSeptember30,2023[21]−TheaccumulateddeficitasofSeptember30,2024,was(135,108,367), an increase from (79,249,114)asofSeptember30,2023[21]Expenses−Researchanddevelopmentexpenseswere64,103 for the nine months ended September 30, 2024, down from 984,882forthesameperiodin2023[14]−Thecompanyreportedasignificantincreaseindepreciationexpenses,totaling1,283,858 for the nine months ended September 30, 2024, compared to 487,052intheprioryear[23]−Stock−basedcompensationfortheninemonthsendedSeptember30,2024,was1,872,504, a decrease from 3,995,020inthesameperiodof2023[23]−Generalandadministrativecostsdecreasedby3,858,934 or 58% for the three months ended September 30, 2024, compared to the same period in 2023, due to headcount reductions[187] - Research and development costs decreased by 275,154or10014,305,000 from notes payable and 9,857,857fromanAt−the−Market(ATM)offeringduringtheninemonthsendedSeptember30,2024[23]−AsofSeptember30,2024,totalnotespayableamountedto58,438,574, an increase of 19.5% from 48,825,320onDecember31,2023[79]−Thecompanyissuedconvertiblesecureddebentureswithaprincipalamountof36,530,320, generating gross proceeds of 35,800,000,withadebtdiscounttotaling21,679,716[80] - The effective interest rate on the debentures was approximately 25.2% as of September 30, 2024[87] - The company entered into a 2023 Term Loan Agreement providing up to 20millioninsecuredtermloans,withaninitialfundingof11,600,000[90][91] - The 2023 Term Loan Agreement includes a 2.5% exit fee of 290,000andbearsinterestat12.59,857,857[123] - The Company entered into a Securities Purchase Agreement to sell shares at a price of 2pershare,resettingconversionpricesunderexistingwarrantsanddebentures[124]−Thecompanyhas8,624,991PublicWarrantsoutstanding,exercisableat11.50 per share, with an expiration date of September 9, 2027[128] - The company assumed 7,175,000 Private Warrants, which are not publicly traded, also exercisable at $11.50 per share[132]